Trial Information

Summary: A Phase II Clinical Trial to Evaluate an Experimental Drug for the Treatment of Men with Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)

Qualified patients will be asked to complete a 12 week treatment period with 6 clinic visits. Following qualification patients will be randomized to receive either study drug or placebo. Patients will be asked to complete study diaries and have urodynamic tests, general clinical labs tests, and general physicals performed during the course of the study.

Patient Inclusion Criteria

  • Males at least 45 years old and meeting diagnostic criteria for diagnosis of LUTS/BOO

Patient Exclusion Criteria

  • Urinary tract infection or chronic inflammation such as prostititis
  • Stone in bladder or ureter
  • Previous surgery to bladder neck or prostate
  • Diagnosis of carcinoma

Contact:

Southeastern Research Group, Inc.
2000 Centre Pointe Boulevard
Tallahassee, FL 32308
Telephone: 850-201-0411
Email:

Profile Page: Southeastern Research Group, Inc., Tallahassee, FL

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:


Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:29:39 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA